Telavancin

55 interactions 4 explained in plain English

Also sold as: Vibativ

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Heparin Heparin Injection Sertraline Levofloxacin Injection Amisulpride Injection Arsenic Trioxide

2 Contraindicated 53 Major

All (55) Contraindicated (2) Major (53)

Contraindicated

Telavancin Heparin Artificial prolongation of aPTT test results Details Telavancin Heparin Injection Lipo-Hepin® Artificial prolongation of aPTT test results Details

Major

Telavancin Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Telavancin Sertraline Explained An increased risk of QT interval prolongation Details Telavancin Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Telavancin Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Telavancin Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Telavancin Arsenic Trioxide Trisenox Increased risk of QT interval prolongation Details Telavancin Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Telavancin Arsenic Trioxide Injection Trisenox Increased risk of QT interval prolongation Details Telavancin Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Telavancin Azithromycin AzaSite An increased risk of QT interval prolongation and torsade de pointes Details Telavancin Alfuzosin UroXatral An increased risk of QT interval prolongation Details Telavancin Anagrelide Agrylin Increased risk of QT interval prolongation Details Telavancin Bedaquiline Sirturo Increased risk of QT interval prolongation Details Telavancin Chloroquine Aralen® Increased risk of QT-interval prolongation Details Telavancin Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Telavancin Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Telavancin Disopyramide Norpace An increased risk of QT interval prolongation Details Telavancin Dofetilide Tikosyn Increased risk of QT interval prolongation Details Telavancin Dolasetron Anzemet An increased risk of QT interval prolongation Details Telavancin Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Telavancin Encorafenib Braftovi Increased risk of QT interval prolongation Details Telavancin Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Telavancin Flecainide Tambocor® An increased risk of QT interval prolongation Details Telavancin Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Telavancin Fostemsavir Rukobia Increased risk of torsade de pointes Details Telavancin Gatifloxacin Ophthalmic Zymar® Increased risk of QT interval prolongation Details Telavancin Gemifloxacin Factive An increased risk of QT interval prolongation Details Telavancin Glasdegib Daurismo Increased risk of QT interval prolongation Details Telavancin Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Telavancin Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Telavancin Granisetron Injection Granisol An increased risk of QT interval prolongation Details Telavancin Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Telavancin Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Telavancin Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Telavancin Ivabradine Corlanor Increased risk of QT prolongation Details Telavancin Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Telavancin Lefamulin Xenleta Increased risk of QT interval prolongation Details Telavancin Lenvatinib Lenvima Increased risk of QT-interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.